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Effect of Three Medicinal Plants Extracts on the Growth of Some Yeasts  Bashar S. Abdulraheem1      Mustafa A. Aldossary2*      Nasir A. Almansour2 1. Southern technical university, Basrah technical institute, Health community department 2.Basrah university, College of Science, Ecology department  Abstract This study conducted to detect the effect of the ethanolic extracts for some medicinal plants on 16 yeast species isolated from the oral cavity of cancer patients, three plants which are  Lavandula angustifolia, Salvia officinalis and  Syzygium aromaticum were used to study their inhibition  bioactivity and compare their effect with three antifungal drugs (Fluconazole, Ketoconazole and Nystatin), the results showed that Ethanolic extract of L. angustifolia exhibited antifungal bioactivity against all yeast species and revealed inhibition zones ranged from 16-36 mm. with highest effect on C. parapsilosis whereas the lowest effect was on species H. uvarum, while the ethanolic extract of S. officinalis and S. aromaticum showed inhibition zones 16-27 mm. and 17-31 mm. respectively, the results showed that the plants extracts having much more effect on the yeasts growth from the antifungal drugs.   Keywords: yeasts, medicinal plants, Ethanolic extracts.  1. Introduction Candida species are a major resident commensal on skin, mucosal surfaces, gastrointestinal tract and the genitourinary tract (Underhill and Iliev, 2014). These species are possible to cause candidal infections in both patients and healthy individuals by the aid of many predisposing factors. Candida genus includes about 200 known species, however about 15 of these species are isolated from patients as a causative for infections. The incidence of infection resulting by Candida species has increased substantially as a cause of increased number of immunocompromised individuals, widespread use of broad-spectrum antibiotics, overuse of immunosuppressive drugs in cancer and organ transplant patients, and increased use of invasive procedures and devices (such as drains and catheters) (Mousavi et al., 2012; Kaur et al., 2014; Yapar, 2014). Susceptibility of Candida to antifungal drugs are various between different species. For instance, some of them are resistant to Azole  group and other to Amphotericin B drug and so on (Al-mamari et al., 2014). Furthermore, the increased use of antifungal agents also contributes in the development of resistance to these agents. Antifungal resistance is related with high mortality rates, more expensive and increased their side effects with more resistant versus antifungal agents. So, there is need to find new therapeutic alternatives acts against fungi with high-efficiency, low side effects and cheap price. For these reasons, it has been the trend to the potential plant extracts to detection of natural effective compounds as antifungal agents, therefore, it was the choice for the best solution to these problems by using of alternative drugs from plants (Zhang et al., 2011;  Martins et al., 2015).  So the aims of this study were extracting natural compounds from three medicinal plants and assess their antifungal bioactivity against some yeast species, and identifying of the most effectiveness compounds in plants extracts by GC-MS analysis.  2. Materials and methods 2.1. Yeast species Sixteen yeasts species were used to study the effect of the medicinal plants on it, all of these yeasts were isolated previously from the oral cavity of cancer patients (Aldossary et al., 2016)   2.2. Collection, Identification and preparation of Plant Samples   Samples of Lavandula angustifolia, Salvia officinalis and  Syzygium aromaticum were purchased from local market in Basrah Province, Iraq. The taxonomic identification of the plants was done by Botanist Prof. Dr. Saher  Abdulabbas, Department of Biology, College of Science, University of  Basrah. After removal of the foreign materials, the samples were washed with distilled water, dried at room temperature and crushed by electric mill to make soft powder, then, powder for each sample was preserved individually in a sterile opaque and airtight bottle in the refrigerator at 4 ̊C until use.  2.3. Preparation of Ethanolic Plant Extracts  The method of extraction was adopted from Harborne (1984) which modified by Almansour (1995).Two hundred grams of powdered plant was put into a thimble paper and placed in the column of Soxhlet extractor. Three hundred milliliters of ethanol 80% was used as a solvent. Extraction process has lasted about 8 hours, after 
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that, the extract was evaporated on a rotary evaporator at 45 ̊C under reduced pressure by vacuum pump to get rid of excess ethanol, then the extract of each plant was weighed and stored in sterile dark bottle at 4 ̊C till use.  Before detection of antifungal bioactivity, we prepared the plant extracts by dissolving 500 mg of each dried extract in1000 ml of distilled water to get the desired concentration (0.5mg/ml) and then sterilized by passing through 0.22µm filter papers (Sosa et al., 2016).  2.4. Gas Chromatography-Mass Spectrum Analysis (GC-MS) This technique was used in our study to identify the bioactive compounds existing in the plant extracts. GC-MS technique was carried out at GC-MS Lab. College of Agriculture, University of Basrah by using GC Shimadzu QP 2010 system and gas chromatograph interfaced to a Mass Spectrometer (GC-MS). It was equipped with fused silica   capillary column (DB5MS) (Length: 30m, Diameter: 0.32 mm, Film thickness: 0.25 µm, composed of 95% methyl poly-siloxane   and 5% phenyl) and Helium gas (99.999%) was used as a carrier gas. Injection was conducted in split mode, and the column temperature was programmed at 50 ̊C for 1 minute with an increase at  a rate of 5 ̊C/minute until reach to final temperature 280 ̊C, then 1µl of sample was injected into the capillary column with fixing the injector and detector temperature at 280 C̊. Separation   process of compounds was conducted as described in (Table 1). Table 1: Analytical circumstances for both GC and MS. No. Gas Chromatography    Mass Spectrometer 1 Column Oven Temp.: 40.0̊C Ion Source Temp.: 200.00 ̊C 2 Injection Temp.: 280.00̊C Interface Temp.: 280.00 ̊C 3 Injection Mode:Split Solvent Cut Time: 3.00 min. 4 Flow Control Mode: Linear Velocity Start Time: 3.00 min. 5 Pressure: 96.1 kPa End Time: 35.00-37.50 min. 6 Total Flow: 56.1 ml/min. ACQ Mode:Scan 7 Colum Flow: 1.71 ml/min. Event Time: 0.50 sec. 8 Linear Velocity: 47.2 cm/sec. Scan Speed: 1250 9 Purge Flow: 3.0 ml/min. Start m/z: 50.00  10 Split Ratio: 30.0 End m/z: 600.00 As a result of this technique for each sample, the percentage of each component was appeared as a peak. The identification of the peaks was done by comparison of their IR (Retention Indices) with those reported in NIST mass spectral library.     2.4. Determination of Ethanolic Plant Extracts Bioactivity A loopful from pure colony culture of each yeast species were suspended in normal saline and adjusted to a turbidity of tube No. 1 in McFarland standards (equivalent to 3x106 fungal cells per ml). 25 µl of the yeast suspension was added on the SDA plates and spread through glass L-shape spreader. The plates were dried for 15 minutes at room temperature and then wells of 6 mm diameter were made using cork borer. 100 µl of each plant extract was added to each well and incubated at 37 ̊ C for 48 hours. The results were read by measurement the inhibition zone diameter manually (Owotadeet al., 2016).  2.5. Preparation of Antifungal Drugs Concentrations  Three antifungal medications (Fluconazole, Ketoconazole and Nystatin) which purchased from local pharmacies were used in present study to comparison their activity with the plant extracts bioactivity. 500 mg of each drug dissolved in 1 liter of distilled water to get the desired concentration 0.5mg/ml.  2.6. Determination of Antifungal Drugs Activity  25 µl of the yeast suspension, which prepared previously, was added on the SDA plates and spread through glass L-shape spreader. The plates were dried for 15 minutes at room temperature and then wells of    6 mm diameter were made using cork borer. 100 µl of each antifungal drug was added to each well and incubated at 37 ̊ C for 48 hours. The results were read by measurement the inhibition zone diameter manually (Saxenaet al., 1995).  3. Results 3.1. GC-MS Analysis  The analysis of each ethanolic plant extract was performed by gas chromatography which coupled with mass spectrometry, for accurate detection of fatty acids. The antifungal compounds were identified by comparison of retention times and computer corresponding of the mass spectra with that of the National Institute of Standards and Technology (NIST 08) library.  
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3.2. L. angustifolia GC-MS for ethanolic extract of L. angustifolia showed the presence of seventy peaks (Figure 1).The compounds matching to the peaks begin from 2(3H)-Furanone, 5-ethenyldihydro-5-methyl-, then end with Triacontane,1-bromo-. The major five peaks belong to compounds that were found in considerable quantities (46.04%)  (Table 2). 
 Figure 1: GC-MS chromatogram peaks of L. angustifol  
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Table 2: Compounds determined in ethanolic extract of L. angustifolia 
 
  3.3.  S. officinalis GC-MS analysis for ethanolic extract of S. officinalis revealed chromatogram with thirty peaks (Figure 2). The compounds matching to the peaks begin from 3-Cyclohexene-1-methanol, alpha.,. alpha., 4-trimethyl-, (S)- then end with 6a, 14a-Methanopicene, perhydro-1,2,4a,6b,9,9,12a-heptamethyl-10-hydroxy-. The major four peaks belong to compounds that were found in considerable quantities (63.57%) (Table 3). 
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 Figure 2: Chromatogram peaks of S. officinalis  Table 3: Compounds determined in ethanolic extract of S. officinalis 
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3.4.  S. aromaticum GC-MS analysis for ethanolic extract of S. aromaticum showed the presence of thirty peaks (Figure 3).The compounds matching to the peaks begin from Phenol, 4-(2-propenyl)-, acetate, then end with gama.-Sitosterol. The major four peaks belong to compounds that were found in considerable quantities (81.49%) (Table 4). 
 Figure 3: GC-MS Chromatogram of S. aromaticum  Table 4: Compounds determined in ethanolic extract of S. aromaticum 
  3.5. Bioactivity of Ethanolic Plant Extracts Against Yeast Species  The plant extracts were shown to be effective against all yeasts isolated during this study and the screening of 
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their bioactivity was detected by presence of inhibition zone around the colony using concentration of 0.5mg/ml for L. angustifolia, S. officinals, and S. aromaticum. Ethanolic extract of L. angustifolia exhibited antifungal bioactivity against all yeast species which isolated in this work. This activity revealed inhibition zones ranged from 16-36 mm. with highest effect on C. parapsilosis whereas the lowest effect was on species H. uvarum. The ethanolic extract of S. officinalis showed antifungal bioactivity against all yeast species with inhibition zones ranged from 16-27 mm. The highest effect was on the S. bayanus x S. cerevisiae while the lowest effect was on H. uvarum. Antifungal effect for S. aromaticum extract showed bioactivity against all yeast species with inhibition zones ranged from 17-31 mm. The highest effect of this extract was on K. marxianus, while the lowest was on H. uvarum (Table 5) ,(Figures 4 to 19).  3.6. Evaluation of Antifungal Activity Against Yeast Species The antifungal concentration for each agent was 0.5 mg/ml, and the wells without addition of drugs served as a control.The result of the susceptibility to antifungal drugs revealed variation in efficacy against yeasts. Candida species showed various degree of susceptibility to antifungal drugs, for instance, C. albicans showed high sensitivity to all three antifungal drugs followed by K. marxianus, while H. uvarum showed significant resistance to all antifungal agents used in this study. Antifungal agents showed different effects against yeast isolates, and nystatin drug was more effective than the other two agents, with the rate of diameter of the inhibitory zone 12.93 mm. (Figures 4 to 19) Table 5: Sensitivity of tested yeast isolates to plant extracts and antifungal drugs 
Yeast species Inhibition zones of plant extracts  Inhibition zones of antifungal drugs L. angustifolia  (mm) S. officinalis  (mm) S. aromaticum  (mm) Fluconazole  (mm) Ketoconazole  (mm) Nystatin  (mm) C. albicans 25 25 29 40 28 18 C. dubliniensis 33 24 27 12 17 14 C.glabrata 27 26 28 0 0 14 C. krusei 23 21 20 18 13 16 C.parapsilosis 36 22 28 23 17 13 C. prunicola 30 25 30 0 12 15 C. tropicalis 18 18 21 0 0 11 H. uvarum 16 16 17 0 0 0 K. exigua 20 21 22 0 6 14 K. marxianus 25 22 31 34 23 17 M. capitatus 21 19 23 0 0 11 Magnusiomycessp. 23 20 19 0 12 8 P. kudriavzevii 19 23 20 9 7 8 P. manshurica 19 18 26 0 8 13 S. bayanus X S. cerevisiae 26 27 30 0 0 18 S. cerevisiae 21 20 27 0 0 17                   Figure 4: C. albicans sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole,C- Nystatin, D- Ketoconazole).   
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                Figure 5: C. dubliniensis sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis ) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                   Figure 6: C. glabrata sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                 Figure 7: C. krusei sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole). 
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                                                Figure 8: C. parapsilosis sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                Figure 9: C. prunicola sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                Figure 10: C. tropicalis sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).  
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                Figure 11: H. uvarum sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                 Figure 12: K. exigua sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                 Figure 13: K. marxianus sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole). 
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               Figure 14: M. capitatus sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                 Figure 15: Magnusiomyces sp. sensitivity to plant extracts and antifungal drugs (Left: A -Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                Figure 16: P. kudriavzevii sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole). 
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                Figure 17: P. manshurica sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).                 Figure 18: S. bayanus x S. cerevisiae sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole). 
 Figure 19: S. cerevisiae sensitivity to plant extracts and antifungal drugs (Left: A- Control, B- L. angustifolia, C- S. aromaticum, D- S. officinalis) (Right: A- Control, B- Fluconazole, C- Nystatin, D- Ketoconazole).  
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4. Discussion In present study, it has been shown that ethanolic extract of L. angustifolia has antifungal activity. Some studies revealed weak inhibitory effect of lavender, whereas other studies reported significant positive effect (Behmanesh et al., 2015). Mahboubi et al. (2008) reported  moderate activity of lavender against fungi. GC-MS analysis for L. angustifolia revealed 5 major compounds were formed 46.04% of 70 different components of plant extract. The highest concentration compound 2H-1-Benzopyran-2-one (coumarin) has been reported for many medical applications such as anticancer, anti-allergic, anticoagulant, anti-inflammatory, antimicrobial and antifungal (Asif, 2015). The second major compound 9,12,15-Octadecatrienoic acid, (Z,Z,Z)- (Linolenic acid), also has antimicrobial activity (Rahman et al., 2014), therefore presence of these two compounds with others provide antifungal activity to extract of L. angustifolia. L. angustifolia is considered a rich source of essential oils which used in aromatherapy, because it possessed different medical applications and lack the toxic influences. The rate of inhibitory zones of L. angustifolia on the yeast isolates was 23.87mm, and the highest positive activity emerged against C. parapsilosis, C. dubliniensis and C. prunicola respectively, while the lowest ffect was on H. uvarum. L. angustifolia has a moderate activity against Candidas species, so our findings agreed with previous studies of Mahboubi et al. (2008), Prusinowska and Smigielski (2013) and Behmanesh et al. (2015).  The rate of inhibitory zones of S. officinalis extract on the yeast isolated in this study was 21.68 mm, and the sensitivity of the yeast species to this crude extract is clearly dissimilar, because some species can more susceptible to the effect of plant extract than others (Nacsa-Farkas et al., 2014).  GC-MS analysis of S. officinalis extract showed 4 major compounds which represented the highest peaks in chromatogram. The major components are: 3-Allyl-6-methoxyphenol (24.27%), 1-(+)-Ascorbic acid 2,6-dihexadecanoate (10.96%), 1-phthalenepropanol, alpha.-ethenyldecahydro-.alpha.,5,5,8a-tetramethyl-2-methyl    (8.01%), and  6-Octadecenoic acid, (Z)-   (20.33%). The essential oils of S. officinalis contain large amounts of monoterpenes which act on germ tube, pesudohyphae and biofilm formation by interaction with lipid components in the cell membrane and then prevent the filamentous form and adhesion of the Candida on the epithelial cells (Sookto et al., 2013).  The highest bioactivity of S. officinalis extract was on the K. marxianus, while the lowest impact was on the H. uvarum. The present result was agreement with previous works of Al-Wahab (2011), Jasim and Abd Al-Khaliq (2011), Karthikeyan et al. (2014) and Rathod et al. (2015). who indicated to effects of S. officinalis extract as the antifungal agent.  The aromatic plants are known to possess antifungal activity, therefore that were used as alternative agents in traditional medicine (Ahmad et al., 2013). Our findings showed that the rate of inhibitory effect of S. aromaticum against yeast isolates was 24.87mm which is higher than influences of L. angustifolia and S. officinalis. Analysis of ethanolic extract for S. aromaticum showed thirty different compounds including five major peaks which represented 88.09% from the total components.  3-Allyl-6-methoxyphenol is a highest presence in the ethanolic extract of S. aromaticum and it is one of eugenol derivatives (m-eugenol) with molecular formula C10H12O2. Eugenol is a phenolic compound, it has bioactivity against fungi by induce the production of H2O2 and elevation level of free Ca2+ in the cytoplasm of cells, which increased permeability changes, leading to damages of plasma membrane and plasma proteins (Kong et al., 2014; Cristina et al., 2015). According to our results, eugenol an essential component in S. aromaticum, that agreement with the findings of many studies which demonstrated the same results (Cristina et al., 2015), and about the activity of eugenol against Candida species, the results of present study are corroborated with the previous studies of Anuj and Sanjay (2010), Kirui et al. (2014) and Wankhede (2015) who observed the high activity of eugenol as antifungal agent. In present study, the highest rate of inhibitory zones for 3 tested antifungal drugs was revealed by nystatin (12.93 mm) and the large effect of this agent was on C. albicans and S. bayanus x S. cerevisiae, while the species H. uvarum showed zero susceptibility to these drugs. The mechanism action of nystatin is based on binding to sterol in the plasma membrane which lead to alteration their permeability and then the yeast cells lose the essential elements for survival (Nenoff et al., 2016). The effect of ketoconazole agent revealed rate of inhibitory zones (8.93 mm) It interferes with cell membrane permeability by decreasing ergosterol synthesis via inhibition of fungal cytochrome P450 (14 α-demethylase) required for conversion of lanosterol to ergosterol (Lewis, 2011). In present work, the high effect of ketoconazole was on the C. albicans followed by k. marxianus, whereas the isolates of C. glabrata, C. tropicalis, H. uvarum, M. capitatus, S. bayanus x S. cerevisiae and S. cerevisiae were showed strong resistance to this drug.  Nine of yeast species resisted the effect of fluconazole completely, while the higher influence was on the C. albicans. The rate of inhibitory zones was 8.5mm which represented the lowest effect among three tested 
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